FDA Approves First Obesity Pill
CHATTANOOGA, Tenn. (WDEF) – The U.S. Food and Drug Administration has approved the first daily pill designed to treat obesity, marking a major milestone in weight loss care. The newly approved medication is an oral version of Wegovy, produced by Novo Nordisk. It contains semaglutide, the same active ingredient used in the injectable versions of Wegovy and Ozempic, as well…